119 related articles for article (PubMed ID: 16009156)
1. Pharmacokinetics and endometrial tissue levels of levonorgestrel after administration of a single 1.5-mg dose by the oral and vaginal route.
Devoto L; Fuentes A; Palomino A; Espinoza A; Kohen P; Ranta S; von Hertzen H
Fertil Steril; 2005 Jul; 84(1):46-51. PubMed ID: 16009156
[TBL] [Abstract][Full Text] [Related]
2. Bioavailability of the Yuzpe and levonorgestrel regimens of emergency contraception: vaginal vs. oral administration.
Kives S; Hahn PM; White E; Stanczyk FZ; Reid RL
Contraception; 2005 Mar; 71(3):197-201. PubMed ID: 15722070
[TBL] [Abstract][Full Text] [Related]
3. Comparison of vaginal and oral administration of emergency contraception.
Mor E; Saadat P; Kives S; White E; Reid RL; Paulson RJ; Stanczyk FZ
Fertil Steril; 2005 Jul; 84(1):40-5. PubMed ID: 16009155
[TBL] [Abstract][Full Text] [Related]
4. Effects of oral and vaginal administration of levonorgestrel emergency contraception on markers of endometrial receptivity.
Meng CX; Marions L; Byström B; Gemzell-Danielsson K
Hum Reprod; 2010 Apr; 25(4):874-83. PubMed ID: 20139427
[TBL] [Abstract][Full Text] [Related]
5. The emergency contraceptive drug, levonorgestrel: a review of post-coital oral and peri-coital vaginal administration for prevention of pregnancy.
Sarkar NN
J Obstet Gynaecol; 2011 Nov; 31(8):703-7. PubMed ID: 22085058
[TBL] [Abstract][Full Text] [Related]
6. Cervical ripening before operative hysteroscopy in premenopausal women: a randomized, double-blind, placebo-controlled comparison of vaginal and oral misoprostol.
Batukan C; Ozgun MT; Ozcelik B; Aygen E; Sahin Y; Turkyilmaz C
Fertil Steril; 2008 Apr; 89(4):966-73. PubMed ID: 17681307
[TBL] [Abstract][Full Text] [Related]
7. A single midcycle dose of levonorgestrel similar to emergency contraceptive does not alter the expression of the L-selectin ligand or molecular markers of endometrial receptivity.
Palomino WA; Kohen P; Devoto L
Fertil Steril; 2010 Oct; 94(5):1589-94. PubMed ID: 19909947
[TBL] [Abstract][Full Text] [Related]
8. Serum levonorgestrel levels and endometrial thickness during extended use of the levonorgestrel-releasing intrauterine system.
Hidalgo MM; Hidalgo-Regina C; Bahamondes MV; Monteiro I; Petta CA; Bahamondes L
Contraception; 2009 Jul; 80(1):84-9. PubMed ID: 19501221
[TBL] [Abstract][Full Text] [Related]
9. Histological characteristics and altered expression of interleukins (IL) IL-13 and IL-15 in endometria of levonorgestrel users with different uterine bleeding patterns.
Rhoton-Vlasak A; Chegini N; Hardt N; Williams RS
Fertil Steril; 2005 Mar; 83(3):659-65. PubMed ID: 15749495
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of single-dose levonorgestrel in adolescents.
Sambol NC; Harper CC; Kim L; Liu CY; Darney P; Raine TR
Contraception; 2006 Aug; 74(2):104-9. PubMed ID: 16860047
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic profiles up to 12 h after administration of vaginal, sublingual and slow-release oral misoprostol.
Aronsson A; Fiala C; Stephansson O; Granath F; Watzer B; Schweer H; Gemzell-Danielsson K
Hum Reprod; 2007 Jul; 22(7):1912-8. PubMed ID: 17488782
[TBL] [Abstract][Full Text] [Related]
12. Oral, rectal, and vaginal pharmacokinetics of misoprostol.
Khan RU; El-Refaey H; Sharma S; Sooranna D; Stafford M
Obstet Gynecol; 2004 May; 103(5 Pt 1):866-70. PubMed ID: 15121558
[TBL] [Abstract][Full Text] [Related]
13. Effect of oral administration of dydrogestrone versus vaginal administration of natural micronized progesterone on the secretory transformation of endometrium and luteal endocrine profile in patients with premature ovarian failure: a proof of concept.
Fatemi HM; Bourgain C; Donoso P; Blockeel C; Papanikolaou EG; Popovic-Todorovic B; Devroey P
Hum Reprod; 2007 May; 22(5):1260-3. PubMed ID: 17227809
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
Zhao RK; Cheng G; Tang J; Song J; Peng WX
Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
[TBL] [Abstract][Full Text] [Related]
15. Effect of levonorgestrel and mifepristone on endometrial receptivity markers in a three-dimensional human endometrial cell culture model.
Meng CX; Andersson KL; Bentin-Ley U; Gemzell-Danielsson K; Lalitkumar PG
Fertil Steril; 2009 Jan; 91(1):256-64. PubMed ID: 18206148
[TBL] [Abstract][Full Text] [Related]
16. Levonorgestrel-only dosing strategies for emergency contraception.
Hansen LB; Saseen JJ; Teal SB
Pharmacotherapy; 2007 Feb; 27(2):278-84. PubMed ID: 17253917
[TBL] [Abstract][Full Text] [Related]
17. Vaginally administered estroprogestinic decreases serum inhibin A and inhibin B levels and reduces endometrial thickness.
Luisi S; Borges LE; Lazzeri L; Dell'Anna A; Severi FM; Petraglia F
Fertil Steril; 2006 Nov; 86(5):1483-7. PubMed ID: 16989826
[TBL] [Abstract][Full Text] [Related]
18. Digitized assessment of mammographic breast density in patients who received low-dose intrauterine levonorgestrel in continuous combination with oral estradiol valerate: a pilot study.
Lundström E; Söderqvist G; Svane G; Azavedo E; Olovsson M; Skoog L; von Schoultz E; von Schoultz B
Fertil Steril; 2006 Apr; 85(4):989-95. PubMed ID: 16580385
[TBL] [Abstract][Full Text] [Related]
19. Rapid endometrial preparation for hysteroscopic surgery with oral desogestrel plus vaginal raloxifene: a prospective, randomized pilot study.
Cicinelli E; Pinto V; Tinelli R; Saliani N; De Leo V; Cianci A
Fertil Steril; 2007 Sep; 88(3):698-701. PubMed ID: 17678902
[TBL] [Abstract][Full Text] [Related]
20. Effects of doxycycline on serum and endometrial levels of MMP-2, MMP-9 and TIMP-1 in women using a levonorgestrel-releasing subcutaneous implant.
Zhao S; Choksuchat C; Zhao Y; Ballagh SA; Kovalevsky GA; Archer DF
Contraception; 2009 Jun; 79(6):469-78. PubMed ID: 19442784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
